Lavaca Capital’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.3K Buy
252
+27
+12% +$2.18K ﹤0.01% 267
2026
Q1
$15.9K Hold
225
﹤0.01% 234
2025
Q4
$17.8K Sell
225
-50
-18% -$3.96K ﹤0.01% 225
2025
Q3
$22.7K Hold
275
﹤0.01% 206
2025
Q2
$22.1K Hold
275
0.01% 203
2025
Q1
$22.1K Hold
275
0.01% 190
2024
Q4
$22.5K Buy
+275
New +$22.9K 0.01% 244
2021
Q3
Sell
-3,822
Closed -$229K 162
2021
Q2
$229K Hold
3,822
0.02% 138
2021
Q1
$232K Buy
+3,822
New +$211K 0.02% 127
2019
Q2
Sell
-3,858
Closed -$164K 234
2019
Q1
$164K Hold
3,858
0.14% 76
2018
Q4
$158K Buy
+3,858
New +$166K 0.16% 71

Other funds holding MET

Lavaca Capital's MET Position: Q2 2026 in Review

Lavaca Capital increased its MetLife (MET) stake by 12% in Q2 2026, buying an estimated $2.18K and bringing the position to 252 shares worth $21.3K. The position accounts for ﹤0.01% of the portfolio, ranked #267.

Lavaca Capital first reported a position in MET in Q4 2018 and has held it in 11 quarters since. The position peaked at $232K in Q1 2021. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Lavaca Capital held 252 shares of MetLife worth $21.3K as of Q2 2026.
  • Lavaca Capital bought 27 MetLife shares in Q2 2026, an estimated $2.18K.
  • MetLife made up ﹤0.01% of Lavaca Capital's portfolio in Q2 2026, its #267 holding.
  • Lavaca Capital first reported a position in MetLife in Q4 2018 and has held it in 11 quarters since.
  • Lavaca Capital's MetLife position peaked at $232K in Q1 2021.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Lavaca Capital's 13F filing for Q2 2026, filed 14 Aug 2026.